POLYPHARMAKOS LIMITED

Active Cambridge

Research and experimental development on biotechnology

4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

POLYPHARMAKOS LIMITED

Research and experimental development on biotechnology

Founded 16 Mar 2016 Active Cambridge, England 4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 18 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 23 Mar 2026 Next due 29 Mar 2027 10 months remaining
Net assets £-9K £3K 2022 year on year
Total assets £122 £38 2022 year on year
Total Liabilities £9K £3K 2022 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

St John's Innovation Centre Cowley Road Cambridge CB4 0WS England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for POLYPHARMAKOS LIMITED (10067504), an active life sciences and medical technology company based in Cambridge, England. Incorporated 16 Mar 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2023
Type micro-entity
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Net Assets, Total Assets & Total Liabilities (2016–2022)

Cash in Bank

N/A

Decreased by £84.00 (-100%)

Net Assets

-£8.53k

Decreased by £2.54k (-42%)

Total Liabilities

£8.66k

Increased by £2.58k (+42%)

Turnover

N/A

Employees

4

Increased by 1 (+33%)

Debt Ratio

7095%

Decreased by 138 (-2%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Mar Year End
2022
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2017Seed
Investor 2Jan 2017Seed
Investor 3Jan 2017Seed

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 7,237 Shares £72.37 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Mar 20231,008£10.08£0.01
27 Feb 20236,229£62.29£0.01

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (7)

Adam Reginald Kelliher
27.5%
Lee Richard Harle
27.5%

Persons with Significant Control

Persons with Significant Control (4)

4 Active

Lee Richard Harle

British

Active
Notified 2 Mar 2023
Residence England
DOB October 1970
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Adam Reginald Kelliher

British,new Zealander

Active
Notified 27 Feb 2023
Residence England
DOB May 1962
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Mr Adam Reginald Kelliher

British,new Zealander

Active
Notified 27 Feb 2023
Residence England
DOB May 1962
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Mr Lee Richard Harle

British

Active
Notified 2 Mar 2023
Residence England
DOB October 1970
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Apr 2026Persons With Significant ControlChange to Mr Adam Reginald Kelliher as a person with significant control on 9 Apr 2026
9 Apr 2026Persons With Significant ControlChange to Mr Lee Richard Harle as a person with significant control on 9 Apr 2026
24 Mar 2026OfficersAppointment of Dr Vjera Magdalenic-Moussavi as director on 24 Mar 2026
23 Mar 2026Confirmation StatementConfirmation statement made on 15 Mar 2026 with updates
18 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
9 Apr 2026 Persons With Significant Control

Change to Mr Adam Reginald Kelliher as a person with significant control on 9 Apr 2026

9 Apr 2026 Persons With Significant Control

Change to Mr Lee Richard Harle as a person with significant control on 9 Apr 2026

24 Mar 2026 Officers

Appointment of Dr Vjera Magdalenic-Moussavi as director on 24 Mar 2026

23 Mar 2026 Confirmation Statement

Confirmation statement made on 15 Mar 2026 with updates

18 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

Recent Activity

Latest Activity

Change to Mr Adam Reginald Kelliher as a person with significant control on 9 Apr 2026

1 months ago on 9 Apr 2026

Change to Mr Lee Richard Harle as a person with significant control on 9 Apr 2026

1 months ago on 9 Apr 2026

Appointment of Dr Vjera Magdalenic-Moussavi as director on 24 Mar 2026

2 months ago on 24 Mar 2026

Confirmation statement made on 15 Mar 2026 with updates

2 months ago on 23 Mar 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 18 Dec 2025